当前位置:首页 - 行情中心 - 申联生物(688098) - 财务分析 - 现金流量表

申联生物

(688098)

  

流通市值:43.86亿  总市值:43.86亿
流通股本:4.11亿   总股本:4.11亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金74,767,697.9734,850,686.15327,771,275.35208,274,801.53
  收到其他与经营活动有关的现金10,580,357.573,360,353.2318,593,903.9713,351,754.79
  经营活动现金流入小计85,348,055.5438,211,039.38346,365,179.32221,626,556.32
  购买商品、接受劳务支付的现金26,721,310.9816,493,455.8463,146,100.1646,070,854.36
  支付给职工以及为职工支付的现金43,725,024.4126,864,266.1986,752,716.7572,145,729.32
  支付的各项税费6,461,858.112,270,549.4915,062,479.9710,943,378.18
  支付其他与经营活动有关的现金47,828,915.5221,143,723.4692,041,835.7779,992,976.84
  经营活动现金流出小计124,737,109.0266,771,994.98257,003,132.65209,152,938.7
  经营活动产生的现金流量净额-39,389,053.48-28,560,955.689,362,046.6712,473,617.62
二、投资活动产生的现金流量:
  收回投资收到的现金352,000,000239,000,0001,025,223,528.42809,923,528.42
  取得投资收益收到的现金679,898.91438,431.612,289,232.371,856,816.84
  处置固定资产、无形资产和其他长期资产收回的现金净额7,000---
  投资活动现金流入小计352,686,898.91239,438,431.611,027,512,760.79811,780,345.26
  购建固定资产、无形资产和其他长期资产支付的现金21,658,558.859,790,027.9684,910,379.6445,128,663.07
  投资支付的现金347,500,000214,000,000946,280,000710,980,000
  投资活动现金流出小计369,158,558.85223,790,027.961,031,190,379.64756,108,663.07
  投资活动产生的现金流量净额-16,471,659.9415,648,403.65-3,677,618.8555,671,682.19
三、筹资活动产生的现金流量:
  取得借款收到的现金--14,000,000-
  收到其他与筹资活动有关的现金16,317.3810,671.9295,346.5146,854.25
  筹资活动现金流入小计16,317.3810,671.9214,095,346.5146,854.25
  偿还债务支付的现金560,000---
  分配股利、利润或偿付利息支付的现金135,22668,25014,347,206.6714,338,485.84
  支付其他与筹资活动有关的现金2,016,651.581,856,900.6919,104,225.37647,565
  筹资活动现金流出小计2,711,877.581,925,150.6933,451,432.0414,986,050.84
  筹资活动产生的现金流量净额-2,695,560.2-1,914,478.77-19,356,085.53-14,939,196.59
四、汇率变动对现金及现金等价物的影响-6.29-2.1541.13-22.88
五、现金及现金等价物净增加额-58,556,279.91-14,827,032.8766,328,383.4253,206,080.34
  加:期初现金及现金等价物余额111,169,093.8111,169,093.844,840,710.3844,840,710.38
  期末现金及现金等价物余额52,612,813.8996,342,060.93111,169,093.898,046,790.72
补充资料:
  净利润-15,042,391.78--48,748,564.39-
  资产减值准备-12,977.32-28,177,425.29-
  固定资产和投资性房地产折旧31,639,949.28-59,189,281.14-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧31,639,949.28-59,189,281.14-
  无形资产摊销4,860,951.56-8,912,564.49-
  处置固定资产、无形资产和其他长期资产的损失46,839.3--35,769.23-
  固定资产报废损失--281,640.19-
  公允价值变动损失-2,157,584.14--883,276.87-
  财务费用162,689.33-54,481.88-
  投资损失-42,443.37--1,785,944.86-
  递延所得税-1,243,546.3--7,933,567.13-
  其中:递延所得税资产减少-1,563,058.77--8,122,940.58-
    递延所得税负债增加319,512.47-189,373.45-
  存货的减少-1,345,091.91-16,682,046.7-
  经营性应收项目的减少-27,898,980.31-5,026,234.92-
  经营性应付项目的增加-33,110,378.82-21,418,535.12-
  现金的期末余额52,612,813.89-111,169,093.8-
  减:现金的期初余额111,169,093.8-44,840,710.38-
  现金及现金等价物的净增加额-58,556,279.91-66,328,383.42-
公告日期2025-08-302025-04-302025-04-302024-10-31
审计意见(境内)标准无保留意见
TOP↑